| HOME >> MEDICINE >> TECHNOLOGY |
Table 52: Novartis AG: key financial ratios 105
Table 53: Pfizer Inc.: key facts 107
Table 54: Pfizer Inc.: key financials ($) 108
Table 55: Pfizer Inc.: key financial ratios 108
Table 56: Germany pharmaceuticals market value forecast: $ million, 2010–15 110
Table 57: Germany size of population (million), 2006–10 111
Table 58: Germany gdp (constant 2000 prices, $ billion), 2006–10 111
Table 59: Germany gdp (current prices, $ billion), 2006–10 111
Table 60: Germany inflation, 2006–10 112
Table 61: Germany consumer price index (absolute), 2006–10 112
Table 62: Germany exchange rate, 2006–10 112
Table 63: Italy pharmaceuticals market value: $ million, 2006–10 114
Table 64: Italy pharmaceuticals market segmentation: % share, by value, 2010 115
Table 65: Italy pharmaceuticals market share: % share, by value, 2010 116
Table 66: Chiesi Farmaceutici SpA: key facts 128
Table 67: GlaxoSmithKline Plc: key facts 131
Table 68: GlaxoSmithKline Plc: key financials ($) 133
Table 69: GlaxoSmithKline Plc: key financials (£) 134
Table 70: GlaxoSmithKline Plc: key financial ratios 134
Table 71: Menarini Group, The: key facts 136
Table 72: Pfizer Inc.: key facts 138
Table 73: Pfizer Inc.: key financials ($) 139
Table 74: Pfizer Inc.: key financial ratios 139
Table 75: Italy pharmaceuticals market value forecast: $ million, 2010–15 141
Table 76: Italy size of population (million), 2006–10 142
Table 77: Italy gdp (constant 2000 prices, $ billion), 2006–10 142
Table 78: Italy gdp (current prices, $ billion), 2006–10 142
Table 79: Italy inflation, 2006–10 143
Table 80: Italy consumer price index (absolute), 2006–10 143
Table 81: Italy exchange rate, 2006–10 143
'/>"/>| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |